Product information

From Health Canada

New search

No match found

No other product was found with the same active ingredient group.

Current status:

Cancelled Post Market

Current status date:

2012-04-16

Original market date: ^{See footnote 1}

1999-05-17

Product name:

8.5% FREAMINE III

DIN:

02158647 Electronic product monograph is not available

Company:

B. BRAUN MEDICAL INC
824 Twelfth Avenue
Bethlehem
Pennsylvania
United States 18018

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

40:20.00

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B05BA01 AMINO ACIDS

Active ingredient group (AIG) number:^{See footnote5}

1535160001

List of active ingredient(s)
Active ingredient(s) ^{See footnote8}	Strength
ALANINE	600 MG / 100 ML
ARGININE	810 MG / 100 ML
DL-METHIONINE	450 MG / 100 ML
GLYCINE	1.19 G / 100 ML
HISTIDINE	240 MG / 100 ML
ISOLEUCINE	590 MG / 100 ML
L-CYSTEINE (L-CYSTEINE HYDROCHLORIDE)	13.9 MG / 100 ML
LEUCINE	770 MG / 100 ML
LYSINE (LYSINE ACETATE)	620 MG / 100 ML
PHENYLALANINE	480 MG / 100 ML
PROLINE	950 MG / 100 ML
SERINE	500 MG / 100 ML
THREONINE	340 MG / 100 ML
TRYPTOPHAN	130 MG / 100 ML
VALINE	560 MG / 100 ML

New search

Same active ingredient group number

Footnotes

Footnote 1

The earliest marketed date recorded in the Drug Product Database.

Return to footnote 1referrer

Footnote 3

The American Hospital Formulary Service permits an easy review of information on a group of drugs with similar activities and uses and allows the reader to determine quickly the similarities and differences among drugs within a group. AHFS® Pharmacologic/Therapeutic Classification© used with permission. © 2022, the American Society of Health-System Pharmacists, Inc. (ASHP). The Data is a part of the AHFS Drug Information®; ASHP is not responsible for the accuracy of transpositions from the original context.

Return to footnote 3referrer

Footnote 4

The purpose of the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system is to be used as a tool for drug utilization research in order to improve quality of drug use. Drugs are divided into different groups according to the organ or system on which they act and their chemical, pharmacological and therapeutical properties.

Return to footnote 4referrer

Footnote 5

The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions:

the first portion (2 digits) identifies the number of active ingredients,
the second portion (5 digits) identifies the unique groups of active ingredients(s),
the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of ‑2% to +10%.

Return to footnote 5referrer

Footnote 8

An asterisk * preceding an active ingredient indicates that the name of the active ingredient has been shortened to fit inside the database's field and that the active ingredient's full name is available on the product's Product Monograph/Veterinary Labelling available above and/or in the NOTES section of the QRYM_ACTIVE_INGREDIENTS extract available in the Drug product database (DPD) data extracts. The following link provides an explanation of the ordering of the data values contained in the DPD data extracts Read me file.

Return to footnote 8referrer

Application information

Related information

Contact us

Version 4.0.3

Report a problem or mistake on this page

"Page details"

Date modified:: 2019-03-01